A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma

被引:0
|
作者
F. Mühr-Wilkenshoff
W. Hinkelbein
I. Ohnesorge
K. J. Wolf
E.-O. Riecken
M. Zeitz
H. Scherübl
机构
[1] University Hospital Benjamin Franklin,Medical Clinic I
[2] University Hospital Benjamin Franklin,Department of Radiotherapy
[3] University Hospital Benjamin Franklin,Department of Radiology
关键词
Esophageal carcinoma; Irinotecan; CPT-11; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:330 / 334
页数:4
相关论文
共 50 条
  • [41] Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
    Tsunoda, A.
    Yasuda, N.
    Nakao, K.
    Narita, K.
    Yamazaki, K.
    Watanabe, M.
    Suzuki, N.
    Kusano, M.
    ONCOLOGY, 2007, 72 (1-2) : 58 - 63
  • [42] A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer
    Muro, K
    Hamaguchi, T
    Ohtsu, A
    Boku, N
    Chin, K
    Hyodo, I
    Fujita, H
    Takiyama, W
    Ohtsu, T
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 955 - 959
  • [43] A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)
    Theodore, C.
    Skoneczna, I.
    Bodrogi, I.
    Leahy, M.
    Kerst, J. M.
    Collette, L.
    Ven, K.
    Marreaud, S.
    Oliver, R. D. T.
    ANNALS OF ONCOLOGY, 2008, 19 (07) : 1304 - 1307
  • [44] Efficacy of combination chemotherapy with irinotecan (CPT-11) plus capecitabine in patients with metastatic or advanced colorectal carcinoma - a dual-centre phase II study: the MAC-6
    Choi, C. K. K.
    Chan, R. T. T.
    Tung, S. Y.
    Lui, L.
    Siu, S.
    Au, G. K. H.
    Ho, J. W. C.
    Law, W. L.
    CLINICAL ONCOLOGY, 2008, 20 (02) : 168 - 175
  • [45] RETROSPECTIVE SINGLE INSTITUTION EXPERIENCE OF CISPLATIN AND IRINOTECAN (CPT-11) AS FIRST-LINE THERAPY IN ADVANCED GASTRIC OR GASTROESOPHAGEAL ADENOCARCINOMA
    Machado, K. K.
    Stelko, G. L. P.
    Oliveira, S. C. R.
    Freitas, H. C.
    Hoff, P. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
  • [46] Phase II study of metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with refractory metastatic colorectal cancer (MCRC).
    Moiseyenko, V.
    Chubenko, V.
    Protsenko, S.
    Mikhalichenko, T.
    Moiseyenko, F.
    Brezhnev, N.
    Moiseyenko, A.
    Kornilov, A.
    Zueva, E.
    Gorchakova, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer
    Abou-Taleb, Hisham A.
    Koshiyama, Masafumi
    Matsumura, Noriomi
    Baba, Tsukasa
    Yamaguchi, Ken
    Hamanishi, Junzo
    Abiko, Kaoru
    Yamanoi, Koji
    Murakami, Ryusuke
    Horikawa, Naoki
    Taha, Ahmed A. A.
    Kitamura, Sachiko
    Konishi, Ikuo
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 (02) : 346 - 356
  • [48] Preliminary report on a phase I/II trial of continuos hepatic arterial infusion (HAI) of irinotecan (CPT-11) in patients (PTS) with locally advanced hepatocellular carcinoma (HCC)
    Piscaglia, Fabio
    Mirarchi, Maria Grazia
    Derenzini, Enrico
    Lanzi, Arianna
    Caprara, Claudia
    Camaggi, Valeria
    Biasco, Guido
    Bolondi, Luigi
    Brandi, Giovanni
    HEPATOLOGY, 2006, 44 (04) : 516A - 516A
  • [49] Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study
    Niitsu, N
    Iijima, K
    Chizuka, A
    ANNALS OF HEMATOLOGY, 2001, 80 (07) : 411 - 416
  • [50] Irinotecan (CPT-11) combined with UFT as first line treatment of advanced colorectal carcinoma-A phase II study.
    Cohen, Y
    Shulman, K
    Idelevich, E
    Ben-Shachar, M
    Honnigman, J
    Haiat, H
    Zidan, J
    Hubert, A
    Kuten, A
    Beny, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 304S - 304S